Efficacy and safety of V1a receptor antagonists in autism spectrum disorder: A meta‐analysis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of V1a receptor antagonists in autism spectrum disorder: A meta‐analysis
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-08-29
DOI
10.1002/jdn.10297
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global prevalence of autism: A systematic review update
- (2022) Jinan Zeidan et al. Autism Research
- Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis
- (2022) Spyridon Siafis et al. Molecular Autism
- Balovaptan vs Placebo for Social Communication in Childhood Autism Spectrum Disorder
- (2022) Eric Hollander et al. JAMA Psychiatry
- Large multicenter randomized trials in autism: key insights gained from the balovaptan clinical development program
- (2022) Suma Jacob et al. Molecular Autism
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): systematic review and meta-regression analysis
- (2020) Spyridon Siafis et al. Molecular Autism
- A phase 2 clinical trial of a vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorder
- (2019) Federico Bolognani et al. Science Translational Medicine
- RoB 2: a revised tool for assessing risk of bias in randomised trials
- (2019) Jonathan A C Sterne et al. BMJ-British Medical Journal
- A Review of Oxytocin and Arginine-Vasopressin Receptors and Their Modulation of Autism Spectrum Disorder
- (2018) Ilaria Cataldo et al. Frontiers in Molecular Neuroscience
- Pharmacological management of hyponatremia
- (2018) Theodosios Filippatos et al. EXPERT OPINION ON PHARMACOTHERAPY
- A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder
- (2017) Daniel Umbricht et al. NEUROPSYCHOPHARMACOLOGY
- Introduction, comparison, and validation of Meta-Essentials : A free and simple tool for meta-analysis
- (2017) Robert Suurmond et al. Research Synthesis Methods
- Predictors of placebo response in pharmacological and dietary supplement treatment trials in pediatric autism spectrum disorder: a meta-analysis
- (2015) A Masi et al. Translational Psychiatry
- Oxytocin and vasopressin: Social neuropeptides with complex neuromodulatory functions
- (2013) E. E. Benarroch NEUROLOGY
- The Challenge of Translation in Social Neuroscience: A Review of Oxytocin, Vasopressin, and Affiliative Behavior
- (2010) Thomas R. Insel NEURON
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started